ProfileDr. Josh Rising is Pew’s director of health care programs, overseeing the health information technology project, the substance use prevention and treatment initiative, and the improving end-of-life care project.
Before joining Pew, Rising helped establish the Office of Policy in the Food and Drug Administration’s Center for Tobacco Products. He also served as health policy analyst for the Connecticut Legislature, focusing on issues of health care access, Medicaid policy, health information technology, and health care quality. He also was legislative affairs director for the American Medical Student Association.
Rising received his medical degree and his master’s degree in public health from Boston University, completed his pediatric residency at the University of California, San Francisco, and trained for a year as a Robert Wood Johnson clinical scholar at Yale University.
Recent WorkView All
More than 20 million Americans struggle with substance use disorder (SUD), and upwards of 33,000 people died from opioid overdose in 2015. Fortunately, effective treatment exists. Medication-assisted treatment (MAT), which pairs U.S. Food and Drug Administration-approved drugs with behavioral therapies, reduces both illicit opioid use and overdose fatalities. Read More
The new leadership at Medicare is reviewing its support for a possible change in hospital billing forms. That single change—adding a number about 14 digits long to identify medical devices — could reap enormous benefits in greater patient safety and save billions in taxpayer money. Previously, Medicare stated that this change could improve the identification of safety problems with... Read More
The Pew Charitable Trusts and several other groups sent a letter Sept. 12 to the Office of the National Coordinator for Health Information Technology asking it to develop certification criteria for electronic health record systems designed for children, with the goal of improving patient safety. Read More